Management of non-vascular complications following renal transplantation using percutaneousapproach

dc.contributor.authorYildirim, Ismail Okan
dc.contributor.authorBerktas, Bayram
dc.contributor.authorSaglik, Semih
dc.contributor.authorPiskin, Turgut
dc.contributor.authorDogan, Murat
dc.contributor.authorSahin, Idris
dc.contributor.authorTaskapan, Hulya
dc.contributor.authorSarac, Kaya
dc.date.accessioned2019-07-17T10:32:23Z
dc.date.available2019-07-17T10:32:23Z
dc.date.issued2018
dc.departmentİnönü Üniversitesien_US
dc.description.abstractOBJECTIVE: Non-vascular complications following renal transplantation can cause graft failure. In this study, we present our two-year experience with percutaneous treatment for non-vascular complications following renal transplantation. PATIENTS AND METHODS: A total of 30 patients who underwent percutaneous radiological treatment between March 2014 and July 2016 were included in the study. RESULTS: Following renal transplantation, a total of 36 percutaneous radiological procedures which includes hydronephrosis secondary to ureteral stricture (n. 15), clinical symptom producing lymphocele due to pressure (14) and creatinine elevated nondilated grafts (n. 7) after excluding other reasons of creatinine elevation, were performed. Six patients received percutaneous treatment for both ureteral stricture and lymphocele. The patients underwent balloon dilatation and double-J ureteral stent due to ureteral stricture. The mean pre- and post-procedural creatinine levels were 4.36 +/- 2.84mg/dL and 2.17 +/- 1.24 mg/dL respectively (p=0.004), indicating a significant difference. For lymphocele treatment, sclerosing agents were injected and lymphatic leakage areas were injected with percutaneous glue. The mean pre- and post-procedural creatinine values were 2.97 +/- 1.78 mg/dL and 1.75 +/- 1.18 respectively (p=0.002), indicating a significant difference. Nephrostomy catheters were placed for patients with elevated creatinine levels and non-dilated collecting system. The mean pre- and post- nephrostomy creatinine levels were 3.55 +/- 2.36 mg/dL and 2.57 +/- 1.82 mg/dL respectively (p>0.05), indicating no statistically significant difference. CONCLUSION: The results of our study suggest that percutaneous treatment is an effective method for the treatment of non-vascular complications following renal transplantation, and, therefore, should be the first option for the preservation of graft functions.en_US
dc.identifier.citationYildirim, IO. Berktas, B. Saglik, S. Piskin, T. Dogan, M. Sahin, I. Taskapan, H. Sarac, K.(2018). Management of non-vascular complications following renal transplantation using percutaneousapproach. Cilt:89. Sayı:1. 86-91 ss.en_US
dc.identifier.endpage91en_US
dc.identifier.issue1en_US
dc.identifier.startpage86en_US
dc.identifier.urihttps://hdl.handle.net/11616/12680
dc.identifier.volume89en_US
dc.language.isoenen_US
dc.publisherEdızıonı luıgı pozzı, vıa panama 68, 00198 rome, ıtalyen_US
dc.relation.ispartofAnnalı ıtalıanı dı chırurgıaen_US
dc.rightsinfo:eu-repo/semantics/restrictedAccessen_US
dc.subjectPostoperatıve lymphocelesen_US
dc.subjectkıdney-transplantatıonen_US
dc.subjectureteral stenosısen_US
dc.subjectsclerotherapyen_US
dc.subjectrecıpıentsen_US
dc.subjectstrıcturesen_US
dc.subjectdraınageen_US
dc.subjectballoonen_US
dc.titleManagement of non-vascular complications following renal transplantation using percutaneousapproachen_US
dc.typeArticleen_US

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: